Celularity Inc. is a regenerative and cellular medicine company. It is developing and commercializing advanced biomaterial products and allogeneic, cryopreserved, placental-derived cell therapies, all derived from the postpartum placenta. Its therapeutic programs that target aging-related diseases, including degenerative diseases, cancer, and immune disorders, using mesenchymal-like adherent stromal cells, T-cells engineered with CAR (CAR T-cells), and genetically modified and unmodified natural killer (NK) cells. It develops, manufactures and commercializes advanced biomaterial products derived from structural tissue components of the postpartum placental tissues, including the umbilical cord. Its advanced biomaterials include Celularity Tendon Wrap, FUSE Bone Void Filler and Celularity Placental Matrix. Its advanced biomaterial products include Biovance, Interfyl and Rebound products. Its platform is Celularity IMPACT (Immuno-Modulatory Placental-derived Allogeneic Cell Therapy).
Ticker SymbolCELUW
CompanyCelularity Inc
CEODr. Robert J. (Bob) Hariri, M.D., Ph.D.
Websitehttps://celularity.com/
FAQs
What is the current price of Celularity Inc (CELUW)?
The current price of Celularity Inc (CELUW) is 0.020.
What is the symbol of Celularity Inc?
The ticker symbol of Celularity Inc is CELUW.
What is the 52-week high of Celularity Inc?
The 52-week high of Celularity Inc is 4.350.
What is the 52-week low of Celularity Inc?
The 52-week low of Celularity Inc is 1.001.
What is the market capitalization of Celularity Inc?
The market capitalization of Celularity Inc is --.
What is the net income of Celularity Inc?
The net income of Celularity Inc is --.
Is Celularity Inc (CELUW) currently rated as Buy, Hold, or Sell?
According to analysts, Celularity Inc (CELUW) has an overall rating of --, with a price target of --.
What is the Earnings Per Share (EPS TTM) of Celularity Inc (CELUW)?
The Earnings Per Share (EPS TTM) of Celularity Inc (CELUW) is --.